{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:45:07Z","timestamp":1792784707880,"version":"4.5.0"},"reference-count":33,"publisher":"American Chemical Society (ACS)","issue":"10","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"name":"Center of Excellence (CoE), Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India","id":[{"id":"https:\/\/ror.org\/0232f6165","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Drug-excipient incompatibility in solid oral dosage forms can generate toxic degradants and compromise potency without producing a visible macroscopic signal in early development. We reported, for the first time, a mechanistically resolved, temperature-sequenced characterization of the solid-state acid\u2212base incompatibility between amlodipine besylate (AMLO; pKa \u2248 9.4) and citric acid (CA; pKa1 3.13; \u0394pKa = 6.27) using six orthogonal techniques: DSC, TGA, isothermal titration calorimetry (ITC), powder X-ray diffractometry with two-dimensional correlation spectroscopy (2D-COS-PXR), FTIR with 2D-COS (2D-COS-FTIR), and stability-indicating HPLC coupled to LC-QToF HRMS. Binary mixtures were thermally stressed at 40\u221290 \u00b0C (7 day isothermal, closed-vial). ITC confirmed a spontaneous, entropy-dominated interaction (\u0394G = \u22125.14 kcal\/mol; \u2212T\u0394S = \u22123.78 kcal\/mol; N \u2248 1:1; KD = 197 \u03bcM) driven by proton transfer to the AMLO dihydropyridine nitrogen with concurrent besylate displacement. DSC showed complete loss of the AMLO Form-I endotherm (onset 201.01 \u00b0C), replaced by a single event at 155.57 \u00b0C with super-additive enthalpy (+19.50 J\/g), consistent with amlodipine citrate salt formation. Application of Noda\u2019s 2D-COS algorithm to temperature-resolved PXRD and FTIR datasets independently resolved a four-stage mechanism, viz., CA surface proton mobilization (40 \u00b0C) \u2192 amlodipine citrate nucleation (50\u221260 \u00b0C) \u2192 besylate counter-ion displacement and d-spacing contraction (\u223c70 \u00b0C) and \u2192 partial amorphization and acid-catalyzed covalent degradation (80\u221290 \u00b0C). Three sequential-order reversals in the 2D-COS-FTIR asynchronous map independently corroborated the Stage-3 crystallographic sequence. HPLC revealed a 4.48-fold enhancement of AMLO loss in the mixture (7.97%) versus pure drug (1.78%), with LC-QToF HRMS identifying four mixture-unique degradants consistent with the four-stage model. This is also the first pharmaceutical application of 2D-COS-PXRD as a mechanistic probe of sequential crystallographic events in drug-excipient incompatibility.<\/jats:p>","DOI":"10.1021\/acs.molpharmaceut.6c00390","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:41:29Z","timestamp":1788435689000},"page":"4857-4871","source":"Crossref","is-referenced-by-count":0,"title":["Sequential Molecular Events in the Solid-State Acid\u2212Base Incompatibility of Amlodipine Besylate and Citric Acid: 2D-COS-PXRD and 2D-COS-FTIR as Orthogonal Probes of Reaction Sequence in Drug-Excipient Solid-State Incompatibility"],"prefix":"10.1021","volume":"23","author":[{"given":"Laltanpuii","family":"Chenkual","sequence":"first","affiliation":[{"name":"National Institute of Pharmaceutical Education and Research-Guwahati (NIPER-G) , , , ,","place":["Guwahati, Assam, India, 781101"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimple S.","family":"Lalchandani","sequence":"additional","affiliation":[{"name":"National Institute of Pharmaceutical Education and Research-Guwahati (NIPER-G) , , , ,","place":["Guwahati, Assam, India, 781101"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavan Kumar","family":"Sathala","sequence":"additional","affiliation":[{"name":"National Institute of Pharmaceutical Education and Research-Guwahati (NIPER-G) , , , ,","place":["Guwahati, Assam, India, 781101"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhuri","family":"Divate","sequence":"additional","affiliation":[{"name":"National Institute of Pharmaceutical Education and Research-Guwahati (NIPER-G) , , , ,","place":["Guwahati, Assam, India, 781101"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arindam","family":"Senapati","sequence":"additional","affiliation":[{"name":"National Institute of Pharmaceutical Education and Research-Guwahati (NIPER-G) , , , ,","place":["Guwahati, Assam, India, 781101"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5822-4053","authenticated-orcid":true,"given":"Pawan Kumar","family":"Porwal","sequence":"additional","affiliation":[{"name":"National Institute of Pharmaceutical Education and Research-Guwahati (NIPER-G) , , , ,","place":["Guwahati, Assam, India, 781101"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"2026100509323359800_cit1","doi-asserted-by":"publisher","first-page":"4560","DOI":"10.1021\/acs.molpharmaceut.7b00677","article-title":"Drug\u2212Excipient Interactions in the Solid State: The Role of Different Stress Factors","volume":"14","author":"Gressl","year":"2017","journal-title":"Mol. Pharmaceutics"},{"key":"2026100509323359800_cit2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/3527607889.ch1","article-title":"Relevance of Solid-state Properties for Pharmaceutical Products","volume-title":"Polymorphism: in the Pharmaceutical Industry 1-19","author":"Hilfiker","year":"2006"},{"key":"2026100509323359800_cit3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/9783527801756.ch9","article-title":"Solid-State Properties","volume-title":"Early Drug Development: Bringing a Preclinical Candidate to the Clinic","author":"Zhang","year":"2018"},{"key":"2026100509323359800_cit4","doi-asserted-by":"publisher","first-page":"15012","DOI":"10.1021\/ja017662o","article-title":"Reactivity Differences of Indomethacin Solid Forms with Ammonia Gas","volume":"124","author":"Chen","year":"2002","journal-title":"J. Am. Chem. Soc."},{"key":"2026100509323359800_cit5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/713738743","article-title":"Crystal Packing and Chemical Reactivity of Two Polymorphs of Flufenamic Acid with Ammonia","volume":"381","author":"Chen","year":"2002","journal-title":"Mol. Cryst. Liq. Cryst."},{"key":"2026100509323359800_cit6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/9781118971147.ch1","article-title":"ICHQ1A(R2) Stability Testing of New Drug Substance and Product and ICHQ1C Stability Testing of New Dosage Forms","volume-title":"ICH Quality Guidelines: An Implementation Guide","author":"Rignall","year":"2017"},{"key":"2026100509323359800_cit7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.trac.2013.06.002","article-title":"Physical stability of pharmaceutical formulations: solid-state characterization of amorphous dispersions","volume":"49","author":"Guo","year":"2013","journal-title":"TrAC, Trends Anal. Chem."},{"key":"2026100509323359800_cit8","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.ijpharm.2018.04.007","article-title":"Current regulatory requirements and practical approaches for stability analysis of pharmaceutical products: A comprehensive review","volume":"543","author":"Sengupta","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"5","key":"2026100509323359800_cit9","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1208\/s12249-023-02573-0","article-title":"Drug-Excipient Compatibility Study Through a Novel Vial-in-Vial Experimental Setup: A Benchmark Study","volume":"24","author":"Jain","year":"2023","journal-title":"AAPS PharmSciTech"},{"issue":"10","key":"2026100509323359800_cit10","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1002\/jps.2600541027","article-title":"Physical and chemical stability testing of tablet dosage forms","volume":"54","author":"Lachman","year":"1965","journal-title":"J. Pharm. Sci."},{"key":"2026100509323359800_cit11","doi-asserted-by":"publisher","first-page":"12393","DOI":"10.1007\/s10973-023-12356-1","article-title":"Analysis of differential scanning calorimetry (DSC): determining the transition temperatures, and enthalpy and heat capacity changes in multicomponent systems by analytical model fitting","volume":"148","author":"Ghanbari","year":"2023","journal-title":"J. Therm. Anal. Calorim."},{"key":"2026100509323359800_cit12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1208\/s12249-025-03240-2","article-title":"Differential Scanning Calorimetry (DSC) in Solid-State Characterization of Solid Dispersions: A Practical Guide","volume":"27","author":"Ding","year":"2026","journal-title":"AAPS PharmSciTech"},{"issue":"21","key":"2026100509323359800_cit13","doi-asserted-by":"publisher","first-page":"8116","DOI":"10.1021\/ja00203a008","article-title":"Two-Dimensional Infrared-Spectroscopy","volume":"111","author":"Noda","year":"1989","journal-title":"J. Am. Chem. Soc."},{"issue":"4","key":"2026100509323359800_cit14","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1366\/0003702904087398","article-title":"Two-Dimensional Infrared (2D IR) Spectroscopy: Theory and Applications","volume":"44","author":"Noda","year":"1990","journal-title":"Appl. Spectrosc."},{"issue":"4","key":"2026100509323359800_cit15","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1177\/0003702818819880","article-title":"Two-Dimensional Correlation Spectroscopy (2D-COS) for Analysis of Spatially Resolved Vibrational Spectra","volume":"73","author":"Lasch","year":"2019","journal-title":"Appl. Spectrosc."},{"issue":"1\u22123","key":"2026100509323359800_cit16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.molstruc.2006.03.053","article-title":"Progress in two-dimensional (2D) correlation spectroscopy","volume":"799","author":"Noda","year":"2006","journal-title":"J. Mol. Struct."},{"issue":"1","key":"2026100509323359800_cit17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1177\/00037028241256397","article-title":"Diverse Applications of Two-Dimensional Correlation Spectroscopy (2D-COS)","volume":"79","author":"Park","year":"2024","journal-title":"Appl. Spectrosc."},{"key":"2026100509323359800_cit18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/B978-0-12-397220-0.00002-7","article-title":"Amlodipine Besylate","volume-title":"Profiles of Drug Substances, Excipients and Related Methodology","author":"Ananchenko","year":"2012"},{"issue":"1","key":"2026100509323359800_cit19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1081\/pdt-120027414","article-title":"Amlodipine besylate-excipients interaction in solid dosage form","volume":"9","author":"Abdoh","year":"2004","journal-title":"Pharm. Dev. Technol."},{"key":"2026100509323359800_cit20","doi-asserted-by":"publisher","first-page":"143461","DOI":"10.1016\/j.molstruc.2025.143461","article-title":"Molecular-level interactions between Amlodipine besylate-Atenolol: Stability and compatibility studies","volume":"1348","author":"Chenkual","year":"2025","journal-title":"J. Mol. Struct."},{"key":"2026100509323359800_cit21","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jpba.2018.07.040","article-title":"Identification and structure elucidation of a new degradation impurity in the multi-component tablets of amlodipine besylate","volume":"162","author":"Gibala","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"2026100509323359800_cit22","doi-asserted-by":"publisher","first-page":"972","DOI":"10.3390\/pharmaceutics14050972","article-title":"Citric Acid: A Multifunctional Pharmaceutical Excipient","volume":"14","author":"Lambros","year":"2022","journal-title":"Pharmaceutics"},{"key":"2026100509323359800_cit23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40538-021-00220-z","article-title":"Physico-chemical and antioxidant properties of barberry juice powder and its effervescent tablets","volume":"8","author":"Naji-Tabasi","year":"2021","journal-title":"Chem. Biol. Technol. Agric."},{"key":"2026100509323359800_cit24","doi-asserted-by":"publisher","first-page":"7599","DOI":"10.1021\/ma300966m","article-title":"Synthesis and Rheological Behavior of Supramolecular Ionic Networks Based on Citric Acid and Aliphatic Diamines","volume":"45","author":"Aboudzadeh","year":"2012","journal-title":"Macromolecules"},{"key":"2026100509323359800_cit25","doi-asserted-by":"publisher","first-page":"6362","DOI":"10.1039\/C2CE26055G","article-title":"Acid\u2212base crystalline complexes and the pKa rule","volume":"14","author":"Cruz-Cabeza","year":"2012","journal-title":"CrystEngComm"},{"key":"2026100509323359800_cit26","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1021\/mp0601345","article-title":"The salt\u2212cocrystal continuum: the influence of crystal structure on ionization state","volume":"4","author":"Childs","year":"2007","journal-title":"Mol. Pharmaceutics"},{"issue":"12","key":"2026100509323359800_cit27","doi-asserted-by":"publisher","first-page":"5279","DOI":"10.1021\/cg101127z","article-title":"Solid Forms of Amlodipine Besylate: Physicochemical, Structural, and Thermodynamic Characterization","volume":"10","author":"Koradia","year":"2010","journal-title":"Cryst. Growth Des."},{"key":"2026100509323359800_cit28","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S0022-0248(99)00819-2","article-title":"Crystallization processes in pharmaceutical technology and drug delivery design","volume":"211","author":"Shekunov","year":"2000","journal-title":"J. Cryst. Growth"},{"key":"2026100509323359800_cit29","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s10973-010-1015-2","article-title":"Thermal behaviour of citric acid and isomeric aconitic acids","volume":"104","author":"Wyrzykowski","year":"2011","journal-title":"J. Therm. Anal. Calorim."},{"key":"2026100509323359800_cit30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.aca.2014.10.031","article-title":"Protein adsorption onto nanomaterials for the development of biosensors and analytical devices: A review","volume":"872","author":"Bhakta","year":"2015","journal-title":"Anal. Chim. Acta"},{"issue":"26","key":"2026100509323359800_cit31","doi-asserted-by":"publisher","first-page":"6665","DOI":"10.1021\/jm701032y","article-title":"Trends in active pharmaceutical ingredient salt selection based on analysis of the Orange Book database","volume":"50","author":"Paulekuhn","year":"2007","journal-title":"J. Med. Chem."},{"issue":"5","key":"2026100509323359800_cit32","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1021\/ja4097384","article-title":"Structural Study of Citrate Layers on Gold Nanoparticles: Role of Intermolecular Interactions in Stabilizing Nanoparticles","volume":"136","author":"Park","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"2026100509323359800_cit33","doi-asserted-by":"publisher","first-page":"128979","DOI":"10.1016\/j.talanta.2025.128979","article-title":"Elucidating the Role of Thermally Driven Free Energy Modulations in the Structural Sustainability of Solid-State Transformations: Effect of Thermal Perturbation on Structural Stability of Cefixime","volume":"298","author":"Senapati","year":"2026","journal-title":"Talanta"}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.6c00390","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/23\/10\/4857\/68127494\/mp6c00390.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/23\/10\/4857\/68127494\/mp6c00390.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:49:15Z","timestamp":1791208155000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article\/23\/10\/4857\/5398085\/Sequential-Molecular-Events-in-the-Solid-State"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":33,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,9,1]]},"published-print":{"date-parts":[[2026,10,5]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6c00390","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]}}}